Filtered By:
Procedure: Gastroschisis Repair

This page shows you your search results in order of date.

Order by Relevance | Date

Total 134 results found since Jan 2013.

Cancers, Vol. 15, Pages 3930: Lynch Syndrome Biopathology and Treatment: The Potential Role of microRNAs in Clinical Practice
ndro Tagliaferri Lynch syndrome (LS), also known as Hereditary Non-Polyposis Colorectal Cancer (HNPCC), is an autosomal dominant cancer syndrome which causes about 2–3% of cases of colorectal carcinoma. The development of LS is due to the genetic and epigenetic inactivation of genes involved in the DNA mismatch repair (MMR) system, causing an epiphenomenon known as microsatellite instability (MSI). Despite the fact that the genetics of the vast majority of MSI-positive (MSI+) cancers can be explained, the etiology of this specific subset is still poorly understood. As a possible new mechanism, it has been...
Source: Cancers - August 2, 2023 Category: Cancer & Oncology Authors: Serena Ascrizzi Grazia Maria Arillotta Katia Grillone Giulio Carid à Stefania Signorelli Asad Ali Caterina Romeo Pierfrancesco Tassone Pierosandro Tagliaferri Tags: Review Source Type: research

Transcript capture and ultradeep long-read RNA sequencing (CAPLRseq) to diagnose HNPCC/Lynch syndrome
Conclusion Our data show that CAPLRseq is an automatable and adaptable workflow for effective transcriptome-based identification of disease variants in a clinical diagnostic setting.
Source: Journal of Medical Genetics - July 21, 2023 Category: Genetics & Stem Cells Authors: Schwenk, V., Leal Silva, R. M., Scharf, F., Knaust, K., Wendlandt, M., Häusser, T., Pickl, J. M. A., Steinke-Lange, V., Laner, A., Morak, M., Holinski-Feder, E., Wolf, D. A. Tags: Open access Cancer genetics Source Type: research

Constitutional MLH1 Methylation Is a Major Contributor to Mismatch Repair-Deficient, MLH1-Methylated Colorectal Cancer in Patients Aged 55 Years and Younger
CONCLUSIONS: Although rare overall, a significant proportion of younger patients with MLH1-methylated CRC had underlying constitutional MLH1 methylation. Routine testing for this high-risk mechanism is warranted in patients aged ≤55 years for a timely and accurate molecular diagnosis that will significantly alter their clinical management while minimizing additional testing.PMID:37433431 | DOI:10.6004/jnccn.2023.7020
Source: Journal of the National Comprehensive Cancer Network : JNCCN - July 11, 2023 Category: Cancer & Oncology Authors: Megan P Hitchins Estela D ámaso Rocio Alvarez Lisa Zhou Yajing Hu Marcio A Diniz Marta Pineda Gabriel Capella Rachel Pearlman Heather Hampel Source Type: research